Physician profile
Bryan K Wilcox
NPI 1891795779
$1,523.56
in general payments reported to CMS, 2019-2025
24 companies · $189 in 2025
The $189 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $353 · 2020: $127 · 2021: $36.32 · 2022: $280 · 2023: $297 · 2024: $241 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $727.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $727.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $347.31 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $163.29 | 2019-2025 | Dupixent |
| Aerin Medical INC. | $153.19 | 2020-2024 | |
| Optinose US, INC. | $147.64 | 2020-2025 | |
| Kaleo, INC. | $87.64 | 2022-2023 | Auvi-Q |
| Genzyme Corporation | $81.84 | 2022-2024 | |
| Intersect Ent, INC. | $68.99 | 2019-2020 | |
| Glaxosmithkline, LLC. | $66.35 | 2021-2025 | Nucala |
| Medtronic USA, INC. | $58.10 | 2019-2020 | |
| Amgen INC. | $41.97 | 2024-2025 | Tavneos |
| Lucid Diagnostics INC. | $40.77 | 2022-2023 | |
| Acclarent, INC | $39.69 | 2019-2020 | |
| Medtronic, INC. | $34.82 | 2023-2024 | Propel |
| Cochlear Americas | $23.89 | 2023 | Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant |
| Carestream Dental, LLC | $21.89 | 2024 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $18.34 | 2023 | |
| Innovation Technologies INC | $18.03 | 2025 | Irrisept |
| Phathom Pharmaceuticals, INC. | $17.56 | 2024 | Voquezna |
| Smith+Nephew, INC. | $16.99 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $16.49 | 2025 | Exparel |
| Astrazeneca Pharmaceuticals LP | $15.50 | 2022 | |
| Karl Storz Endoscopy-America | $15.27 | 2024 | Tele Pack |
| Novartis Pharmaceuticals Corporation | $14.23 | 2025 | |
| Abbvie INC. | $13.77 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Wilcox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.